Quarterly report [Sections 13 or 15(d)]

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.26.3
Description of Business and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2026
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following is a summary of cash, cash equivalents and restricted cash at September 30, 2026 and December 31, 2025:

 

(in thousands)   September 30,
2026
    December 31,
2025
 
Cash and cash equivalents   $ 28,677     $ 47,998  
Restricted cash – long-term     341       335  
Cash, cash equivalents and restricted cash   $ 29,018     $ 48,333  
Schedule of Diluted Weighted Average Shares Outstanding Stock options and warrants were excluded for the nine months ended September 30, 2026 because, for each quarter, the exercise price plus unrecognized compensation cost exceeded the average market price of the Company’s common stock.

 

    Three months ended     Nine months ended  
(in thousands)   September 30,
2026
    September 30,
2025
    September 30,
2026
    September 30,
2025
 
Incremental shares from RSUs included in diluted net income per share     -       -       17       -  
                                 
Potentially dilutive securities excluded because their effect would have been anti-dilutive:                                
                                 
Stock Options     2,297       162       2,297       162  
Unvested RSUs     3,151       -       - (1)     -  
Vested unissued shares of common stock     -       179       -       179  
Warrants     7       7       7       7  
Total     5,455       348       2,304       348  

 

(1) The 3,151 thousand unvested RSUs outstanding at September 30, 2026 were included in the computation of diluted net income per share for the nine months ended September 30, 2026 under the treasury stock method, resulting in 17 thousand incremental shares.